These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 8949569

  • 1. Growth hormone, insulin-like growth factor I and its binding proteins 1 and 3 in last trimester intrauterine growth retardation with increased pulsatility index in the umbilical artery.
    Larsen T, Main K, Andersson AM, Juul A, Greisen G, Skakkebaek NE.
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):315-9. PubMed ID: 8949569
    [Abstract] [Full Text] [Related]

  • 2. Third trimester fetal growth and umbilical venous blood concentrations of IGF-1, IGFBP-1, and growth hormone at term.
    Spencer JA, Chang TC, Jones J, Robson SC, Preece MA.
    Arch Dis Child Fetal Neonatal Ed; 1995 Sep; 73(2):F87-90. PubMed ID: 7583612
    [Abstract] [Full Text] [Related]

  • 3. Fetal and maternal plasma insulin-like growth factors and binding proteins in pregnancies with appropriate or retarded fetal growth.
    Holmes R, Montemagno R, Jones J, Preece M, Rodeck C, Soothill P.
    Early Hum Dev; 1997 Jul 24; 49(1):7-17. PubMed ID: 9179534
    [Abstract] [Full Text] [Related]

  • 4. Changes observed in Doppler studies of the fetal circulation in pregnancies complicated by pre-eclampsia or the delivery of a small-for-gestational-age baby. I. Cross-sectional analysis.
    Harrington K, Carpenter RG, Nguyen M, Campbell S.
    Ultrasound Obstet Gynecol; 1995 Jul 24; 6(1):19-28. PubMed ID: 8528796
    [Abstract] [Full Text] [Related]

  • 5. The maternal insulin-like growth factor (IGF) and IGF-binding protein response to trisomic pregnancy during the first trimester: a possible diagnostic tool for trisomy 18 pregnancies.
    Miell JP, Langford KS, Jones JS, Noble P, Westwood M, White A, Nicolaides KH.
    J Clin Endocrinol Metab; 1997 Jan 24; 82(1):287-92. PubMed ID: 8989275
    [Abstract] [Full Text] [Related]

  • 6. Developmental pattern of fetal growth hormone, insulin-like growth factor I, growth hormone binding protein and insulin-like growth factor binding protein-3.
    Pirazzoli P, Cacciari E, De Iasio R, Pittalis MC, Dallacasa P, Zucchini S, Gualandi S, Salardi S, David C, Boschi S.
    Arch Dis Child Fetal Neonatal Ed; 1997 Sep 24; 77(2):F100-4. PubMed ID: 9377129
    [Abstract] [Full Text] [Related]

  • 7. Differential effects of low birthweight and intrauterine growth restriction on umbilical cord blood insulin-like growth factor concentrations.
    Tzschoppe A, Riedel C, von Kries R, Struwe E, Rascher W, Dörr HG, Beckmann MW, Schild RL, Goecke TW, Flyvbjerg A, Frystyk J, Dötsch J.
    Clin Endocrinol (Oxf); 2015 Nov 24; 83(5):739-45. PubMed ID: 26118397
    [Abstract] [Full Text] [Related]

  • 8. Biophysical and biochemical markers at 30-34 weeks' gestation in the prediction of adverse perinatal outcome.
    Valiño N, Giunta G, Gallo DM, Akolekar R, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2016 Feb 24; 47(2):194-202. PubMed ID: 26094952
    [Abstract] [Full Text] [Related]

  • 9. The hemodynamics of late-onset intrauterine growth restriction by MRI.
    Zhu MY, Milligan N, Keating S, Windrim R, Keunen J, Thakur V, Ohman A, Portnoy S, Sled JG, Kelly E, Yoo SJ, Gross-Wortmann L, Jaeggi E, Macgowan CK, Kingdom JC, Seed M.
    Am J Obstet Gynecol; 2016 Mar 24; 214(3):367.e1-367.e17. PubMed ID: 26475425
    [Abstract] [Full Text] [Related]

  • 10. Maternal hemodynamics, fetal biometry and Doppler indices in pregnancies followed up for suspected fetal growth restriction.
    Roberts LA, Ling HZ, Poon LC, Nicolaides KH, Kametas NA.
    Ultrasound Obstet Gynecol; 2018 Oct 24; 52(4):507-514. PubMed ID: 29607557
    [Abstract] [Full Text] [Related]

  • 11. Fetal cardiac function in late-onset intrauterine growth restriction vs small-for-gestational age, as defined by estimated fetal weight, cerebroplacental ratio and uterine artery Doppler.
    Pérez-Cruz M, Cruz-Lemini M, Fernández MT, Parra JA, Bartrons J, Gómez-Roig MD, Crispi F, Gratacós E.
    Ultrasound Obstet Gynecol; 2015 Oct 24; 46(4):465-71. PubMed ID: 26112274
    [Abstract] [Full Text] [Related]

  • 12. The relationship among intrauterine growth, insulinlike growth factor I (IGF-I), IGF-binding protein-3, and bone mineral status in newborn infants.
    Akcakus M, Koklu E, Kurtoglu S, Kula M, Koklu SS.
    Am J Perinatol; 2006 Nov 24; 23(8):473-80. PubMed ID: 17094045
    [Abstract] [Full Text] [Related]

  • 13. Serum insulin-like growth factor-binding protein-3 (IGFBP-3) levels and IGFBP-3 protease activity in normal, abnormal, and multiple human pregnancy.
    Langford KS, Nicolaides KH, Jones J, Abbas A, McGregor AM, Miell JP.
    J Clin Endocrinol Metab; 1995 Jan 24; 80(1):21-7. PubMed ID: 7530257
    [Abstract] [Full Text] [Related]

  • 14. Maternal serum insulin-like growth factor (IGF-I) and binding proteins IGFBP-1 and IGFBP-3 at 11-13 weeks' gestation in pregnancies delivering small for gestational age neonates.
    Sifakis S, Akolekar R, Kappou D, Mantas N, Nicolaides KH.
    Eur J Obstet Gynecol Reprod Biol; 2012 Mar 24; 161(1):30-3. PubMed ID: 22245615
    [Abstract] [Full Text] [Related]

  • 15. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M, Jansson C, Rosberg S, Albertsson-Wikland K.
    J Clin Endocrinol Metab; 1996 Nov 24; 81(11):3902-8. PubMed ID: 8923836
    [Abstract] [Full Text] [Related]

  • 16. Prediction of small-for-gestational-age neonates: screening by biophysical and biochemical markers at 30-34 weeks.
    Bakalis S, Peeva G, Gonzalez R, Poon LC, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2015 Oct 24; 46(4):446-51. PubMed ID: 25826154
    [Abstract] [Full Text] [Related]

  • 17. Impact of fetal growth restriction on body composition and hormonal status at birth in infants of small and appropriate weight for gestational age.
    Verkauskiene R, Beltrand J, Claris O, Chevenne D, Deghmoun S, Dorgeret S, Alison M, Gaucherand P, Sibony O, Lévy-Marchal C.
    Eur J Endocrinol; 2007 Nov 24; 157(5):605-12. PubMed ID: 17984240
    [Abstract] [Full Text] [Related]

  • 18. Biophysical and biochemical markers at 35-37 weeks' gestation in the prediction of adverse perinatal outcome.
    Valiño N, Giunta G, Gallo DM, Akolekar R, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2016 Feb 24; 47(2):203-9. PubMed ID: 26224608
    [Abstract] [Full Text] [Related]

  • 19. Use of placental growth factor and uterine artery doppler pulsatility index in pregnancies involving intrauterine fetal growth restriction or preeclampsia to predict perinatal outcomes.
    Gomez-Roig MD, Mazarico E, Sabria J, Parra J, Oton L, Vela A.
    Gynecol Obstet Invest; 2015 Feb 24; 80(2):99-105. PubMed ID: 25924544
    [Abstract] [Full Text] [Related]

  • 20. Placental insufficiency among high-risk pregnancies with a normal umbilical artery resistance index after 32weeks.
    Geerts L, Van der Merwe E, Theron A, Rademan K.
    Int J Gynaecol Obstet; 2016 Oct 24; 135(1):38-42. PubMed ID: 27515046
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.